Yahoo Finance Insider Buying: The Immunovia AB (publ) (STO:IMMNOV) Director Just Bought kr500k Worth Of Shares
Even if it's not a huge purchase, we think it was good to see that Hans Johansson, the Director of Immunovia AB (publ) (STO:IMMNOV) recently shelled out kr500k to buy stock, at kr98.47 per share. While we're hesitant to get too excited about a purchase of that size, we do note it increased their holding by a solid 22%.
View our latest analysis for Immunovia
The Last 12 Months Of Insider Transactions At Immunovia
In fact, the recent purchase by Hans Johansson was the biggest purchase of Immunovia shares made by an insider individual in the last twelve months, according to our records. That means that an insider was happy to buy shares at around the current price of kr106. That means they have been optimistic about the company in the past, though they may have changed their mind. We do always like to see insider buying, but it is worth noting if those purchases were made at well below today's share price, as the discount to value may have narrowed with the rising price. The good news for Immunovia share holders is that an insider was buying at near the current price. The only individual insider to buy over the last year was Hans Johansson.
You can see the insider transactions (by individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!
There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.
Does Immunovia Boast High Insider Ownership?
For a common shareholder, it is worth checking how many shares are held by company insiders. We usually like to see fairly high levels of insider ownership. Immunovia insiders own about kr591m worth of shares. That equates to 28% of the company. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.
What Might The Insider Transactions At Immunovia Tell Us?
It is good to see the recent insider purchase. We also take confidence from the longer term picture of insider transactions. But on the other hand, the company made a loss last year, which makes us a little cautious. When combined with notable insider ownership, these factors suggest Immunovia insiders are well aligned, and quite possibly think the share price is too low. That's what I like to see! So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. For instance, we've identified 5 warning signs for Immunovia (2 don't sit too well with us) you should be aware of.
Of course Immunovia may not be the best stock to buy. So you may wish to see this free collection of high quality companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.
We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.
